[Value of Lysyl-plasminogen-urokinase sequential treatment in thrombolytic therapy].
D000368:Aged; D004341:Drug Evaluation; D010450:Endopeptidases / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000008:administration & dosage / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D010958:Plasminogen; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator
Intérêt du traitement séquentiel lysyl-plasminogène-urokinase en thérapeutique thrombolytique.